http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765154-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929b318e94c2e38925f8328e5f407510 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a09ad4cfcb6fea6926a64e71d40c0bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41047ec02e82ea94f465b58c39027ef3 |
| publicationDate | 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2765154-C2 |
| titleOfInvention | Methods for treatment of malignant tumor using pyrimidine and pyridine compounds with btk inhibitory activity |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to the treatment of lymphoma. The use of the therapeutically effective amount of a compound selected from N-[(1-acryloylpiperidine-4-yl)methyl]-5-(4-phenoxyphenyl)pyrimidine-4,6-diamine and 1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidine-4-yl)amino)methyl)-4-fluoropiperidine-1-yl)prop-2-en-1-one, their pharmaceutically acceptable salts, tautomers and stereoisomers, including their mixtures in all ratios, for the treatment or prevention of myeloproliferative disorders or malignant tumor is disclosed, where malignant tumor is selected from non-Hodgkin lymphoma of mantle zone cells and non-Hodgkin diffuse B-large cell lymphoma, including the abc subtype.EFFECT: invention provides for the treatment of lymphoma without undesirable effects outside targets.4 cl, 8 dwg, 2 tbl, 2 ex |
| priorityDate | 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 690.